Day 1

Acute pancreatitis

General introduction (Péter Hegyi)

Calcium-dependent interactions between pancreatic acinar and stellate cells as well as pancreatic macrophages drive the development of acute pancreatitis (Ole Petersen)

Discoveries by Hungarian researchers in the field of acute pancreatitis: Basic research overview (Zoltán Rakonczay)

The role of Orai1 channel in pancreatic ductal physiology and pathology (József Maléth)

SARS-CoV-2 S protein subunit 1 elicits Ca2+ influx-dependent Ca2+ signals in pancreatic stellate cells and macrophages in situ (Julia Gerasimenko)

Summary of the 10-year clinical research experience of HPSG (Andrea Szentesi)

Accurate prediction of risk of organ failure within the first day of acute pancreatitis using mathematical modeling and a smart phone (David Whitcomb)

HORDEN - NOVEL multipronged method of treatment of acute pancreatitis (Aleksei Katsintsev)


Early chronic pancreatitis

Early chronic pancreatitis from the HPSG perspective (Katalin Márta)


The EFFect Of dietary fat content on the Recurrence of pancreaTitis (EFFORT): protocol of a multicenter randomized controlled trial (Márk Félix Juhász)

Heterozygous SPINK1 deficiency promotes progressive pancreatitis in mice (Alexandra Demcsák)

Cystic pancreatic incidentaloma (Vinciane Rebours)

The role of cathepsin B in the early events of pancreatitis (Andrea Geisz)

Observational longitudinal multicentre investigation of acute pancreatitis (GOULASH PLUSH) (Alexandra Mikó)

A simple method for diagnosing early chronic pancreatitis (Péter Jenő Hegyi)

Screening, surveillance and targeted therapy in pancreatic cancer (Julia Mayerle)

Advanced pre-clinical therapies for acute pancreatitis (Vijay Singh)


Pediatric pancreatitis

Pediatric pancreatitis from the HPSG perspective (Andrea Párniczky)

Pediatric acute pancreatitis in the twenty-twenties (Maisam Abu-El-Haija)

Surgical approach to debilitating pancreatitis in children: past, present and future (Jaimie Nathan)

Tackling the global problem of drug adverse events, using the prototypich example of asparaginase-associated pancreatitis (Sohail Husain)

The quest for treatments for pancreatic diseases (Stephen Pandol)


Social Event - Cultural performance


Day 2

Chronic pancreatitis

Genetic risk of chronic pancreatitis in Hungarians: 10 years of HPSG studies (Miklós Sahin-Tóth)

Genetics in chronic pancreatitis: can we still find novel associations? (Jonas Rosendahl)

Controversial genetic risk factors in chronic pancreatitis: from CASR to CEL (Eszter Hegyi)

Promoter variants in the chymotrypsinogen C gene in patients with chronic pancreatitis (Balázs Németh)

In-hospital patient education markedly reduces alcohol consumption after alcohol-induced acute pancreatitis (Rita Nagy)

Metabolic associated fatty liver disease is associated with a more severe acute pancreatitis: a prospective cohort analysis of 2053 cases (Szilárd Váncsa)

In-hospital rate of gastrointestinal bleeding among acute pancreatitis patients: A systematic review and meta-analysis (Marie Anne Engh)

Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis (Gergő Berke)


Pancreatic solid tumors

Pancreas tumors from the HPSG perspective: future plans (Bálint Erőss)

Identification of novel genetic risk factors for PDAC by SNP functional annotation (Federico Canzian)

Polygenic and multifactorial risk scores in PDAC risk prediction (Daniele Campa)

The effect of bile on pancreatic cancer, the importance of mucins (Eleonóra Gál)

Managing of individuals at high risk for familial pancreatic cancer (Thomas Gress)

Recent advances in pancreatic cancer therapy (Ashok Saluja)

Pancreatic cancer surveillance: current state of affairs and future opportunities (Marco Bruno)

Advanced EUS-guided imaging and tissue acquisition for the differential diagnosis of solid pancreatic lesions (Juan Enrique Domínguez-Munoz)

ZIP4 is a novel therapeutic target in pancreatic cancer (Min Li)


Cystic fibrosis

Physiological and pathophysiological roles of CTRF in pancreatic exocrine and endocrine function (Viktória Venglovecz)

Early results from the Hungarian CFRPD registry data (Adrienn Kéri)

Personalized medicine: pancreas-on-a-chip to study CFRD (Anjaparavanda Naren)

Hirshberg lecture in pancreas surgery


Day 3

Rare diseases and biomarkers

Autoimmune pancreatitis from the HPSG perspective (László Czakó)

Is there a chance for simple pancreatic ductal adenocarcinoma biomarkers? (Ewa Malecka-Wojciesko)

EUS with FNA/FNB for pancreatic cancer: The future "standard of care" in the field of individualized medicine (Christian Gheorghe)

Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma (Stefania Bunduc)

Evolution in management of acute pancreatitis over the past 7 years in collaboration with HPSG (Imola Török)

Complicated cases of pancreatic pathology in clinical practice (Natalya Gubergrits)


Center of Excellence in Pancreatic Diseases (CEPD) corner

Multidisciplinary approach in pancreatology - first experiencing and potentials (Tamás Hussein)

Management of pancreatic fluid collections - guidelines and daily practice (Attila Szijártó)

Pancreas diseases at Semmelweis University: on the way to Champions League (Ákos Szücs)

Hungarian interventional radiological solutions of hepato-pancreatico-biliary diseases (Attila Doros)

Intensive therapeutic aspects of pancreatic diseases (László Zubek)

Step-up approach in the management of acute necrotizing pancreatitis in our practice (István Hritz)


Closing remarks (Péter Hegyi)